Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.
作者信息
Muhiddin K A, Turner P
出版信息
Postgrad Med J. 1985 Aug;61(718):665-77. doi: 10.1136/pgmj.61.718.665.
Abstract
摘要
相似文献
1
Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.是否存在理想的抗心律失常药物？一篇综述——特别提及I类抗心律失常药物。
Postgrad Med J. 1985 Aug;61(718):665-77. doi: 10.1136/pgmj.61.718.665.
2
The clinical pharmacology of antiarrhythmic drugs.抗心律失常药物的临床药理学。
Cardiovasc Clin. 1984;14(3):153-90.
3
Antiarrhythmic agents.抗心律失常药物。
Med J Aust. 1984 Nov 24;141(11):718-23.
4
New antiarrhythmic drugs: their place in therapy.新型抗心律失常药物：它们在治疗中的地位。
Drugs. 1981 Nov;22(5):363-400. doi: 10.2165/00003495-198122050-00002.
5
Potentially significant drug interactions of class III antiarrhythmic drugs.III类抗心律失常药物潜在的显著药物相互作用。
Drug Saf. 2003;26(6):421-38. doi: 10.2165/00002018-200326060-00004.
6
A benefit-risk assessment of class III antiarrhythmic agents.Ⅲ类抗心律失常药物的获益-风险评估
Drug Saf. 2002;25(12):847-65. doi: 10.2165/00002018-200225120-00003.
7
[Clinical evaluation of the anti-arrhythmic properties and cardiohemodynamic effects of the basic anti-arrhythmia agents].[抗心律失常基本药物的抗心律失常特性及心脏血流动力学效应的临床评估]
Farmakol Toksikol. 1985 Jan-Feb;48(1):5-10.
8
[Classification and mechanism of action of anti-arrhythmia drugs].[抗心律失常药物的分类及作用机制]
Wien Med Wochenschr. 1994;144(14-15):338-42.
9
A rational scientific basis for subclassification of antiarrhythmic drugs.抗心律失常药物亚分类的合理科学依据。
Trans Am Clin Climatol Assoc. 1986;97:43-52.
10
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part I.
Int J Clin Pharmacol Ther Toxicol. 1981 Apr;19(4):139-51.
引用本文的文献
1
Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach.基于网络药理学方法探索沙库巴曲缬沙坦治疗心律失常的机制
Front Cardiovasc Med. 2022 Apr 13;9:829484. doi: 10.3389/fcvm.2022.829484. eCollection 2022.
2
[Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].[I类抗心律失常药物：作用机制、禁忌证及当前适应证]
Herzschrittmacherther Elektrophysiol. 2010 Dec;21(4):228-38. doi: 10.1007/s00399-010-0090-1.
本文引用的文献
1
The renal excretion of mexiletine (Kö 1173) under controlled conditions of urine pH.在尿液pH值可控条件下美西律（Kö 1173）的肾脏排泄情况。
Br J Clin Pharmacol. 1974 Feb;1(1):86-7. doi: 10.1111/j.1365-2125.1974.tb00214.x.
2
Antifibrillatory action.抗纤颤作用。
J Physiol. 1962 Mar;160(3):470-82. doi: 10.1113/jphysiol.1962.sp006860.
3
Ventricular fibrillation precipitated by cardiac catheterization; complete recovery of the patient after 45 minutes.心脏导管插入术诱发心室颤动；患者在45分钟后完全康复。
J Am Med Assoc. 1950 Jun 24;143(8):717-20. doi: 10.1001/jama.1950.02910430009003.
4
APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIES.药物代谢在药物毒性研究中的应用。
Ann N Y Acad Sci. 1965 Mar 12;123:273-86. doi: 10.1111/j.1749-6632.1965.tb12268.x.
5
QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.奎尼丁晕厥。慢性房性心律失常治疗期间发生的阵发性室性颤动。
Circulation. 1964 Jul;30:17-26. doi: 10.1161/01.cir.30.1.17.
6
INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY.羟化不足作为苯妥英钠毒性的一个原因
Neurology. 1964 Jun;14:542-8. doi: 10.1212/wnl.14.6.542.
7
A comparison of tests for antifibrillatory action.抗纤颤作用测试的比较
Br J Pharmacol Chemother. 1961 Dec;17(3):424-32. doi: 10.1111/j.1476-5381.1961.tb01129.x.
8
Urinary pH.尿液酸碱度
J Urol. 1959 Feb;81(2):339-43. doi: 10.1016/S0022-5347(17)66022-1.
9
Torsades de pointes as a manifestation of mexiletine toxicity.尖端扭转型室速作为美西律中毒的一种表现。
Am Heart J. 1980 Dec;100(6 Pt 1):878-80. doi: 10.1016/0002-8703(80)90070-8.
10
Displacement of phenytoin from plasma binding sites by salicylate.
Clin Pharmacol Ther. 1980 Feb;27(2):165-9. doi: 10.1038/clpt.1980.25.
Zotero 插件